NC
ELOX

NewSquare Capital’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

NewSquare Capital’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1
Closed -$4 – 941
2023
Q2 		$4 Hold
1
– – ﹤0.01% 853
2023
Q1 		$3 Hold
1
– – ﹤0.01% 886
2022
Q4 		$2 Buy
+1
New +$5 ﹤0.01% 828

Other funds holding ELOX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NewSquare Capital's ELOX Position: Q3 2023 in Review

NewSquare Capital sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q3 2023, closing a stake of 1 share — an estimated $4 sold.

NewSquare Capital first reported a position in ELOX in Q4 2022 and held it in 3 quarters. The position peaked at $4 in Q2 2023. 18 funds tracked by Wall St. Rank hold ELOX as of Q3 2023.

  • NewSquare Capital reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • NewSquare Capital sold 1 Eloxx Pharmaceuticals, Inc. Common Stock share in Q3 2023, an estimated $4.
  • NewSquare Capital first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • NewSquare Capital's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $4 in Q2 2023.
  • 18 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q3 2023.

Based on NewSquare Capital's 13F filing for Q3 2023, filed 3 Nov 2023.